Back to Results
First PageMeta Content
Medical statistics / Pharmacology / Number needed to treat / Riluzole / Number needed to harm / Evidence-based medicine / Absolute risk reduction / Carotid endarterectomy / Placebo / Medicine / Health / Epidemiology


Volume 1, number 7 Implementing NNTs Sponsored by an educational grant from Aventis Pharma
Add to Reading List

Document Date: 2004-01-01 13:10:14


Open Document

File Size: 440,59 KB

Share Result on Facebook

City

London / /

Company

Aventis Pharma Limited / Hayward Group plc / Gustafson AB / /

Country

United States / /

Currency

GBP / /

Facility

University College London / British Library / /

/

IndustryTerm

pharmaceuticals / pharmaceutical industry / cancer treatment / hypertension treatment / communication tool / healthcare provision / hypertension Treating / healthcare / angina treatment / /

MedicalCondition

blisters / strokes / hypertension / cancer / mild hypertension Treating hypertension / ALS / neutropenia / stroke / nausea / vertigo / heart disease / amyotrophic lateral sclerosis / severe hypertension / Severe hypersensitivity / pain / vomiting / febrile illness / ischaemic stroke / tachycardia / angina / dizziness / hepatic disease / fasciculations / /

MedicalTreatment

Carotid endarterectomy / acupressure / mechanical ventilation / /

NaturalFeature

Kings Hill / /

Organization

University College London / European Union / NHS / /

Person

Martin Duerden / Anita Burrell / /

/

Position

Field J. General / Edwina Watt Business Director / Team Assistant to the Health Economics Unit / physician / Lecturer / Consultant / Adviser / Director / Healthcare Relations Business / /

Product

donepezil / riluzole / Rilutek / /

PublishedMedium

Bandolier / /

URL

http /

SocialTag